ADDvise Group AB (publ) (ADDV-A.ST)

SEK 11.2

(1.36%)

Net Income Summary of ADDvise Group AB (publ)

  • ADDvise Group AB (publ)'s latest annual net income in 2023 was 103.5 Million SEK , up 27.62% from previous year.
  • ADDvise Group AB (publ)'s latest quarterly net income in 2024 Q3 was 11.8 Million SEK , down -60.4% from previous quarter.
  • ADDvise Group AB (publ) reported an annual net income of 81.1 Million SEK in 2022, up 2791.27% from previous year.
  • ADDvise Group AB (publ) reported an annual net income of 2.8 Million SEK in 2021, down -80.84% from previous year.
  • ADDvise Group AB (publ) reported a quarterly net income of 29.8 Million SEK for 2024 Q2, down -30.54% from previous quarter.
  • ADDvise Group AB (publ) reported a quarterly net income of 11.8 Million SEK for 2024 Q3, down -60.4% from previous quarter.

Annual Net Income Chart of ADDvise Group AB (publ) (2023 - 2007)

Historical Annual Net Income of ADDvise Group AB (publ) (2023 - 2007)

Year Net Income Net Income Growth
2023 103.5 Million SEK 27.62%
2022 81.1 Million SEK 2791.27%
2021 2.8 Million SEK -80.84%
2020 14.63 Million SEK 260.63%
2019 4.05 Million SEK 479.35%
2018 -1.07 Million SEK 81.59%
2017 -5.81 Million SEK -1662.63%
2016 372 Thousand SEK 103.35%
2015 -11.09 Million SEK -133.1%
2014 -4.76 Million SEK -4.27%
2013 -4.56 Million SEK -27.01%
2012 -3.59 Million SEK -1207.27%
2011 -275 Thousand SEK 94.24%
2010 -4.77 Million SEK 0.0%
2009 - SEK 100.0%
2008 -971 Thousand SEK -188.19%
2007 1.1 Million SEK 0.0%

Peer Net Income Comparison of ADDvise Group AB (publ)

Name Net Income Net Income Difference
Acarix AB (publ) -77.83 Million SEK 232.967%
ADDvise Group AB (publ) 103.5 Million SEK 0.0%
Arcoma AB 2.56 Million SEK -3936.661%
Bactiguard Holding AB (publ) -138.38 Million SEK 174.793%
BICO Group AB (publ) -835.7 Million SEK 112.385%
Boule Diagnostics AB (publ) 24.97 Million SEK -314.381%
CellaVision AB (publ) 130.3 Million SEK 20.573%
Clinical Laserthermia Systems AB (publ) -79.79 Million SEK 229.712%
Chordate Medical Holding AB (publ) -29.18 Million SEK 454.614%
C-Rad AB (publ) 35.52 Million SEK -191.311%
Duearity AB (publ) -26.19 Million SEK 495.189%
Dignitana AB (publ) -17.36 Million SEK 696.095%
Episurf Medical AB (publ) -94.8 Million SEK 209.177%
Getinge AB (publ) 2.41 Billion SEK 95.709%
Scandinavian Real Heart AB (Publ) -67.97 Million SEK 252.257%
Iconovo AB (publ) -45.89 Million SEK 325.521%
Integrum AB (publ) 4.03 Million SEK -2466.66%
Luxbright AB (publ) -25.37 Million SEK 507.88%
Mentice AB (publ) -2.81 Million SEK 3774.121%
OssDsign AB (publ) -130.49 Million SEK 179.315%
Paxman AB (publ) 8.33 Million SEK -1142.497%
Promimic AB (publ) -9.22 Million SEK 1222.316%
Qlife Holding AB (publ) -159.95 Million SEK 164.705%
SciBase Holding AB (publ) -55.58 Million SEK 286.201%
ScandiDos AB (publ) -14.64 Million SEK 806.629%
Sectra AB (publ) 428.38 Million SEK 75.84%
Sedana Medical AB (publ) -59.61 Million SEK 273.623%
Senzime AB (publ) -134.14 Million SEK 177.153%
SpectraCure AB (publ) -20.44 Million SEK 606.335%
Stille AB 26.64 Million SEK -288.426%
Vitrolife AB (publ) -3.85 Billion SEK 102.688%
Xvivo Perfusion AB (publ) 91.82 Million SEK -12.721%